Can you provide the average price target for BIOCEPT INC stock?
6 analysts have analysed BIOC and the average price target is 4.08 USD. This implies a price increase of 838.15% is expected in the next year compared to the current price of 0.4349.
BIOCEPT INC (BIOC) Forecast, Price Target & Analyst Ratings
NASDAQ:BIOC • US09072V6002
Current stock price
0.4349 USD
-0.07 (-13.05%)
At close:
0.39 USD
-0.04 (-10.32%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOCEPT INC (BIOC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Nov 20, 2023
- Period
- Q3 / 2023
- EPS Estimate
- -$2.78
- Revenue Estimate
- 613.02K
Price Target Details & History
Consensus Price Target and Range
Mean target
$4.08
Upside
+ 838.15%
From current price of $0.43 to mean target of $4.08, Based on 6 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for BIOC. The average price target is 4.08 USD. This implies a price increase of 838.15% is expected in the next year compared to the current price of 0.4349.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
BIOC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BIOC.
In the previous month the buy percentage consensus was at a similar level.
BIOC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-04-14 | Maxim Group | Downgrade | Buy -> Hold |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Nov 20, 2023
- Period
- Q3 / 2023
- EPS Estimate
- -$2.78
- Revenue Estimate
- 613.02K
- Revenue Q2Q
- -39.12%
- EPS Q2Q
- 71.87%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
BIOC is expected to report earnings on 11/20/2023. The consensus EPS estimate for the next earnings is -2.78 USD and the consensus revenue estimate is 613.02K USD.
Full Analyst Estimates 2023 - 2025
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.46M 396.56% | 61.249M 123.05% | 25.858M -57.78% | 2.526M -90.23% | 6.601M 161.32% | 21.906M 231.86% | |
| EBITDA YoY % growth | -14.38M 35.02% | -879K 93.89% | -30.328M -3,350.28% | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.47M 32.91% | -2.409M 84.43% | -31.983M -1,227.65% | -24.438M 23.59% | -23.525M 3.74% | -17.27M 26.59% | |
| Operating Margin | -56.34% | -3.93% | -123.69% | -967.47% | -356.39% | -78.84% | |
| EPS YoY % growth | -1.89 99.36% | -0.10 94.71% | -43.07 -42,970.00% | -5.66 86.86% | -1.41 75.14% | -0.87 38.41% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -2.78 71.87% | -0.47 98.57% |
| Revenue Q2Q % growth | 613.02K -39.12% | 625.26K -97.58% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -5.408M 46.76% | -5.553M 82.64% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.57%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-18.32%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOCEPT INC / BIOC Forecast FAQ
What is the next earnings date for BIOC stock?
BIOCEPT INC (BIOC) will report earnings on 2023-11-20, after the market close.
What are the consensus estimates for BIOCEPT INC (BIOC) next earnings?
The consensus EPS estimate for the next earnings of BIOCEPT INC (BIOC) is -2.78 USD and the consensus revenue estimate is 613.02K USD.
What is the expected long term growth rate for BIOCEPT INC (BIOC)?
The expected long term growth rate for BIOCEPT INC (BIOC) is -18.32%.